ATE466858T1 - 3-arylisoxazol-4-carbonylbenzofuranderivative - Google Patents

3-arylisoxazol-4-carbonylbenzofuranderivative

Info

Publication number
ATE466858T1
ATE466858T1 AT06819173T AT06819173T ATE466858T1 AT E466858 T1 ATE466858 T1 AT E466858T1 AT 06819173 T AT06819173 T AT 06819173T AT 06819173 T AT06819173 T AT 06819173T AT E466858 T1 ATE466858 T1 AT E466858T1
Authority
AT
Austria
Prior art keywords
sup
derivatives
carbonylbenzofuran
arylisoxazole
cognitive
Prior art date
Application number
AT06819173T
Other languages
English (en)
Inventor
Bernd Buettelmann
Bo Han
Henner Knust
Matthias Nettekoven
Andrew Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE466858T1 publication Critical patent/ATE466858T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
AT06819173T 2005-11-09 2006-10-27 3-arylisoxazol-4-carbonylbenzofuranderivative ATE466858T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05110503 2005-11-09
PCT/EP2006/067879 WO2007054444A2 (en) 2005-11-09 2006-10-27 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives

Publications (1)

Publication Number Publication Date
ATE466858T1 true ATE466858T1 (de) 2010-05-15

Family

ID=37876981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06819173T ATE466858T1 (de) 2005-11-09 2006-10-27 3-arylisoxazol-4-carbonylbenzofuranderivative

Country Status (13)

Country Link
US (1) US7388025B2 (de)
EP (1) EP1948648B1 (de)
JP (1) JP2009514924A (de)
KR (1) KR101103129B1 (de)
CN (1) CN101304994B (de)
AT (1) ATE466858T1 (de)
AU (1) AU2006311092B2 (de)
BR (1) BRPI0618383A2 (de)
CA (1) CA2628667A1 (de)
DE (1) DE602006014185D1 (de)
ES (1) ES2341131T3 (de)
IL (1) IL190867A0 (de)
WO (1) WO2007054444A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100828891B1 (ko) * 2006-02-23 2008-05-09 엘지이노텍 주식회사 Ｌｅｄ 패키지
BR112014006784A2 (pt) 2011-09-26 2017-04-04 Koninklijke Philips Nv sistema de geração de imagens e método
BR112014017989B1 (pt) 2012-02-01 2021-02-23 Basf Se processo para a fabricação de papel ou papelão
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
BR112014020640B1 (pt) 2012-03-01 2021-05-25 Basf Se processo de fabricação de papel, papelão ou papel-cartão
WO2014001278A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2014001279A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
CA2876778A1 (en) 2012-06-26 2014-01-03 Saniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
KR20150033679A (ko) 2012-06-26 2015-04-01 사니오나 에이피에스 페닐 트리아졸 유도체 및 이의 gabaa 수용체 복합체 조절용 용도
WO2014001280A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
JP6293170B2 (ja) 2013-01-11 2018-03-14 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 紙および板紙の製造方法
BR102019014802A2 (pt) 2018-07-20 2020-02-04 Boehringer Ingelheim Int difluorometil-fenil triazóis
TWI901650B (zh) * 2020-03-26 2025-10-21 匈牙利商羅特格登公司 啶及吡啶并〔３，４－ｃ〕嗒衍生物
EP4126858B1 (de) * 2020-03-26 2026-03-18 Richter Gedeon Nyrt. Dihydro-2-pyrrolo[3,4-c pyridin-derivate als gabaa a5 rezeptormodulatoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1314191B1 (it) 1999-10-18 2002-12-06 Recordati Chem Pharm Derivati isossazolcarbossamidici
IL159697A0 (en) 2001-07-05 2004-06-20 Synaptic Pharma Corp Substituted anilinic piperidines as mch selective antagonists
BR0211742A (pt) * 2001-08-06 2004-08-24 Pharmacia Italia Spa Derivados de aminoisoxazole ativos como inibidores de cinase
GB0128160D0 (en) * 2001-11-23 2002-01-16 Merck Sharp & Dohme Novel compounds

Also Published As

Publication number Publication date
DE602006014185D1 (de) 2010-06-17
AU2006311092B2 (en) 2011-05-12
IL190867A0 (en) 2008-11-03
EP1948648B1 (de) 2010-05-05
EP1948648A2 (de) 2008-07-30
WO2007054444A3 (en) 2007-06-28
US7388025B2 (en) 2008-06-17
AU2006311092A1 (en) 2007-05-18
CN101304994A (zh) 2008-11-12
CA2628667A1 (en) 2007-05-18
US20070105922A1 (en) 2007-05-10
WO2007054444A2 (en) 2007-05-18
ES2341131T3 (es) 2010-06-15
KR20080065697A (ko) 2008-07-14
KR101103129B1 (ko) 2012-01-04
BRPI0618383A2 (pt) 2011-08-30
JP2009514924A (ja) 2009-04-09
CN101304994B (zh) 2011-06-29

Similar Documents

Publication Publication Date Title
IL190867A0 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
ATE438632T1 (de) Aryl-4-ethinylisoxazolderivate
IL189762A0 (en) Isoxazolo derivatives as gaba a alpha5 inverse agonists
HUS2100028I1 (hu) ERBB I. típusú receptor tirozinkináz-gátló N4-fenil-kinazolin-4-amin származékok és rokon vegyületeik a hiperproliferatív betegségek kezelésére
NO20071967L (no) Imidazo-benzodiazepinderivater
IL186777A0 (en) (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor
MX2010005717A (es) Derivados de isoxazolo-piridina.
EA200901373A1 (ru) Аминогетероциклические соединения
MX2009014001A (es) Derivados de isoxazol-imidazol.
MX2011011477A (es) Derivados de isoxazol-piridazina.
WO2007062999A3 (en) 1,5-substituted indol-2-yl amide derivatives
NO20082719L (no) Aryl-isoksazol-4-yl-oksadiazolderivater
MX2011011489A (es) Derivados de isoxazol-piridina.
MX2011011273A (es) Derivados de isoxazol-pirazol.
WO2007143523A8 (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
MX2011011490A (es) Derivados de isoxazol-tiazol como agonistas inversos del receptor de acido gamma-aminobutirico a (gaba a), para usarse en el tratamiento de trastornos cognitivos.
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
TW200736251A (en) Aryl-isoxazol-4-yl-imidazole derivatives
ATE466007T1 (de) 5-substituierte indol-2-carbonsäureamidderivate
IL184439A0 (en) 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1
TW200700390A (en) Metabolites for nk-1 antagonists for emesis
EA200701758A1 (ru) Замещённые арильные производные 1,4-пиразина
ATE378339T1 (de) Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2
EA200801114A1 (ru) Производные карбазола в качестве функциональных 5-htлигандов

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1948648

Country of ref document: EP